GSK3B and malignant colon neoplasm: In summary, we have demonstrated that inhibition of GSK-3β by lithium could induce the production of ROS and suppress the proliferation of colorectal cells by the downregulation of activity of NF-κB and NF-κB-mediated target genes transcription, which may be of benefit for clinical outcome in patients suffering from colon cancer in future.